Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    An NIH website-transition notice appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:17:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T00:24:22.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with minimal chrome, replacing the full study record content. As a result, the study's details, contacts, and locations are not visible to the user.
    Difference
    17%
    Check dated 2026-09-23T00:30:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.6 to v3.7.0, marking a new revision of the study record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-09-15T23:47:43.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    An updated page revision tag now displays v3.6.6, replacing the previous v3.6.5. This indicates the ClinicalTrials.gov study page has been refreshed to a newer version.
    Difference
    0.1%
    Check dated 2026-09-01T19:13:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, replacing the previous page version.
    Difference
    0.1%
    Check dated 2026-08-11T08:27:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.